AzTrials
AzTrials

Healthy AgingNCT04882527

Modulating Prospective Memory in Older Adults With Non-invasive Brain Stimulation

A study testing Non-invasive brain stimulation in people with Healthy Aging, run by University of Bern at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Prospective memory is the ability to remember to carry out intentions with a certain delay (e.g. remember to buy stamps when passing a postal office). Prospective memory tasks require a large degree of self-initiated retrieval and in the absence of a prompt to recall, people must 'remember to remember' by their own… Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Aging
What is being tested?
Non-invasive brain stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
106 participants
Where
1 siteSwitzerland
Study dates
28 Jun 2021to 31 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • No cognitive impairments
  • Fluent in German
  • Right-handed
  • Normal or corrected-to-normal vision
  • Non-smokers
  • Written informed consent

Who cannot join

  • Current/lifetime severe psychiatric or neurological disorder
  • Metal implants in the head area
  • Psychotropic medication
  • Dermatosis
  • Current/lifetime alcohol abuse
  • Magnetisable implants

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Universitätsklinik für Alterspsychiatrie und Psychotherapie

    Bern, 3008

Other trials in Switzerland

About this study

Official title: Modulating Prospective Memory in Older Adults With Noninvasive Brain Stimulation

Prospective memory is the ability to remember to carry out intentions with a certain delay (e.g. remember to buy stamps when passing a postal office). Prospective memory tasks require a large degree of self-initiated retrieval and in the absence of a prompt to recall, people must 'remember to remember' by their own volition. Thus, prospective memory is a challenge - especially in old age with increasing health-related prospective memory demands.

Previous studies reported links between neural activity in specific brain regions and prospective memory performance. Yet, the mere occurrence of a change in brain activity in concomitance with performance of a behavioral task is not sufficient to confirm a causal relationship between the two phenomena. Therefore, this study aims to apply non-invasive brain stimulation to facilitate or inhibit activity in different brain regions presumed to be functionally associated with prospective memory. Additional to the prospective memory tasks, the investigators will implement control tasks (i.e., attention) to assess whether stimulation will specifically enhance prospective memory performance or whether other cognitive functions will be modulated additionally.

It is hypothesized that stimulation will lead to changes in prospective memory functioning. Further, the investigators expect that facilitation of attentional processes might be linked to prospective memory improvements.

Read the detailed description

This study aims to modulate neural activity in the left and right inferior frontal lobe as well as in the right superior parietal lobe via high-definition transcranial direct current stimulation (HD-tDCS) in older adults. There is evidence from functional magnetic resonance imaging (fMRI) studies that these areas are involved in prospective memory performance in younger and older adults but a causal relation between activity in these areas and responses in prospective memory tasks has not been established so far.

A double blind, sham-controlled, parallel group design will be applied. Healthy older adults (n=105) will participate in two separate sessions: During the first baseline session, no stimulation is applied. For the second session, participants will then be randomly assigned to one of seven experimental groups (cathodal vs. anodal right inferior frontal lobe (rIFL); cathodal vs. anodal left inferior frontal lobe (lIFL); cathodal vs. anodal right superior parietal lobe (rSPL); or sham). Real stimulation will be applied during 20 minutes with one Milliamp (mA). In case of sham stimulation (i.e., control intervention), the electrode positions and the attachment procedures correspond to those of real tDCS but the electrical current will only be ramped up to one mA and switched off completely after 30 s of stimulation.

The primary objective of this study is the modulation of prospective memory performance in a computer-based task via tDCS. Further, this study aims to clarify the role of attentional control for prospective memory performance, as both processes seem to recruit similar neural structures. Additionally, naturalistic and self-rated prospective memory performance will be assessed.

It is hypothesized that stimulation of the right inferior frontal lobe will lead to changes in prospective memory performance and attentional processes. Whether cathodal or anodal stimulation will enhance performance is not clear yet, since previous fMRI studies were inconsistent about activity changes in older adults. Further, the investigators expect that anodal stimulation of the left inferior frontal cortex may lead to faster responses to prospective memory stimuli, whereas cathodal stimulation of the same area may lead to prolonged reaction times. It is hypothesized that attentional control will not be affected by stimulation of the left inferior frontal lobe. Finally, the investigators expect that anodal stimulation of the right superior parietal cortex will lead to better prospective memory and attentional control performance, whereas cathodal stimulation will have detrimental effects on both functions.

Conditions
Healthy Aging
Being tested
Non-invasive brain stimulation, Sham stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-invasive brain stimulationDevice

    Also called high-definition transcranial direct current stimulation, HD-tDCS, Soterix medical

    Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

  • Sham stimulationDevice

    The electrode positions and the attachment procedures correspond to those of real tDCS but the electrical current will only be ramped up to 1 mA and switched off completely after 30 s of stimulation.

Study groups in NCT04882527
Study groupRoleWhat they receive
anodal stimulation of the rIFLExperimentalAnodal stimulation over the right inferior frontal lobe
Receives: Device: Non-invasive brain stimulation
cathodal stimulation of the rIFLExperimentalCathodal stimulation over the right inferior frontal lobe
Receives: Device: Non-invasive brain stimulation
anodal stimulation of the lIFLExperimentalAnodal stimulation over the left inferior frontal lobe
Receives: Device: Non-invasive brain stimulation
cathodal stimulation of the lIFLExperimentalCathodal stimulation over the left inferior frontal lobe
Receives: Device: Non-invasive brain stimulation
anodal stimulation of the rSPLExperimentalAnodal stimulation over the right superior parietal lobe
Receives: Device: Non-invasive brain stimulation
cathodal stimulation of the rSPLExperimentalCathodal stimulation over the right superior parietal lobe
Receives: Device: Non-invasive brain stimulation
sham stimulationSham comparatorSham stimulation over either of the three real stimulation areas
Receives: Device: Sham stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prospective memory performance

    Assessed with a computer task. Number of correct answers given to prospective memory stimuli.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), fixed to 14 minutes

  2. Prospective memory reaction time

    Assessed with a computer task. Reaction times of answers given to prospective memory stimuli.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), fixed to 14 minutes

  3. Executive controlling functioning

    Assessed with a computer task (ANT - Attentional Network Task). Interference between answers given to congruent and incongruent stimuli.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), task fixed to 6 minutes

  4. Flexibility performance

    Assessed with a computer task (TAP- Test of Attentional Performance). Number of correct answers.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after intervention), 3 minutes

  5. Inhibition errors

    Assessed with a computer task (Test of Attentional Performance). Sum of incorrect responses to no-go stimuli.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after intervention), 2 minutes

  6. Divided attention misses

    Assessed with a computer task (TAP - Test of Attentional Performance). Sum of missed target stimuli.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after intervention), 3 minutes 30 seconds

  7. Flexibility reaction-time

    Assessed with a computer task (TAP - Test of Attentional Performance). Mean/ median of reactions times of correct responses.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after intervention), 3 minutes

  8. Inhibition reaction time

    Assessed with a go/no-go computer task (TAP -Test of Attentional Performance). Mean/ median of reactions times to correct responses.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after intervention), 2 minutes

  9. Divided attention reaction time

    Assessed with a computer-based task (Test of Attentional Performance). Median reaction time of correct answers.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: directly after stimulation), 3 minutes 30 seconds

Secondary outcomes (5)
  1. Alerting network functioning

    Assessed with a computer task (ANT - Attentional Network Task). Contrasting reaction times of answers given to stimuli with alerting cues to those without alerting cues.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), task fixed to 6 minutes

  2. Orienting network functioning

    Assessed with a computer task (ANT - Attentional Network Task). Contrasting reaction times of answers given to stimuli with reliable spatial cues to those without spatial cues.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), task fixed to 6 minutes

  3. Ongoing-task performance

    Assessed with a computer task. Number of correctly answered ongoing task stimuli in the course of the prospective memory task.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), fixed to 14 minutes

  4. Ongoing-task reaction time

    Assessed with a computer task. Mean/median response time of correct ongoing task answers in the course of the prospective memory task.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), fixed to 14 minutes

  5. Ongoing-task intra-individual coefficient of variation

    Assessed with a computer task. Variability of response times (i.e., within-person fluctuation in response latency) to ongoing task stimuli in the course of the prospective memory task.

    Change from baseline to intervention session, difference between intervention groups.

    Measured: During both sessions (for stimulation session: during intervention), fixed to 14 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2021
  2. Study start28 Jun 2021
  3. Primary completion31 Oct 2023
  4. Study completion31 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04882527
Sponsor's protocol ID
2019-01599
Other IDs
2019
Status last verified
Dec 2023
First submitted
6 May 2021
Last updated
12 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Schmidt N, Menendez-Granda M, Munger R, Reber TP, Bayen UJ, Gumusdagli FE, Hering A, Joly-Burra E, Kliegel M, Peter J. Modulating prospective memory and attentional control with high-definition transcranial current stimulation: Study protocol of a randomized, double-blind, and sham-controlled trial in healthy older adults. PLoS One. 2023 Aug 7;18(8):e0289532. doi: 10.1371/journal.pone.0289532. eCollection 2023.

    PubMed 37549139

Questions about this trial

What is this clinical trial studying?

A study testing Non-invasive brain stimulation in people with Healthy Aging, run by University of Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prospective memory performance (time frame: During both sessions (for stimulation session: during intervention), fixed to 14 minutes). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04882527, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in